RNA interference (RNAi) is a widespread antiviral mechanism triggered by virus-produced double-stranded RNAs (dsRNAs). In <i>Caenorhabditis elegans</i> antiviral RNAi involves a RIG-I-like RNA helicase, termed DRH-1 (dicer related RNA helicase 1), that is not required for classical RNAi triggered by artificial dsRNA. Currently, whether antiviral RNAi in <i>C. elegans</i> involves novel factors that are dispensable for classical RNAi remains to be an open question. To address this question, we designed and carried out a genetic screen that aims to identify novel genes involved in worm antiviral RNAi. By introducing extra copies of known antiviral RNAi genes into the reporter worms we managed to reject alleles derived from 4 known antiviral RNAi genes, including DRH-1 coding gene, during the screen. Our genetic screen identified altogether 25 alleles which were assigned to 11 candidate genes and 2 known antiviral RNAi genes through genetic complementation tests. Using mapping-by-sequencing strategy we identified one of the candidate genes as <i>
rsd-6</i>, a gene that helps maintain genome integrity through an endogenous gene silencing pathway but was not known to be required for antiviral RNAi. More importantly we found that two of the candidate genes are required for antiviral RNAi targeting Orsay virus, a natural viral pathogen of <i>C. elegans</i>, but dispensable for classical RNAi. Since <i>
drh-1</i> is so far the only antiviral RNAi gene not required for classical RNAi, we believe that our genetic screen led to identification of novel worm genes that may target virus-specific features to function in RNAi.<b>Importance</b>In nematode worms <i>
drh-1</i> detects virus produced double-stranded RNA (dsRNA) thereby to specifically contribute to antiviral RNA silencing. To identify <i>
drh-1</i>-like genes with dedicated function in antiviral RNAi we recently carried out a genetic screen that was designed to automatically reject all alleles derived from 4 known antiviral silencing genes, including <i>
drh-1</i> Of the 11 candidate genes identified we found two of them to be required for antiviral silencing targeting a natural viral pathogen of <i>C. elegans</i>, but not for classical RNA silencing triggered by artificial dsRNA. We believe that these two genes are novel components of worm antiviral RNAi, considering the fact that <i>
drh-1</i>, the only known antiviral RNAi gene that is dispensable for classical RNAi. This genetic screen also identified <i>
rsd-6</i>, a gene that maintains genome integrity under unfavorable condition, as key regulator of worm antiviral silencing, demonstrating an interplay between antiviral immunity and genome integrity maintenance.